Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach

Detalhes bibliográficos
Autor(a) principal: Ferreira, João Paulo Morais
Data de Publicação: 2020
Outros Autores: Araújo, Francisco, Dores, Jorge, Santos, Lélita, Pape, Estevão, Reis, Mónica, Chipepo, Árcia, Nascimento, Edite, Baptista, Ana, Pires, Vanessa, Marques, Carlos, Lages, Adriana S., Conceição, João, Laires, Pedro A., Pelicano-Romano, João, Alão, Sílvia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/105884
https://doi.org/10.1007/s13300-020-00868-0
Resumo: Introduction: Hypoglycemia leading to hospitalization is associated with adverse economic outcomes, although the real burden is unknown. The HIPOS-WARD (Hypoglycemia In Portugal Observational Study-Ward) aimed to characterize ward admissions due to hypoglycemia episodes in treated patients with diabetes and assess their economic impact to the National Health System. Methods: Observational, cross-sectional study, conducted in 16 Portuguese centers for 22 months. The applied microcosting approach was based on healthcare resource data, collected from patients’ charts upon ward admission until discharge, and unitary costs from official/ public data sources. Absenteeism was also estimated for active workers on the basis of the human capital approach. Results: Of the 176 patients with diabetes mellitus enrolled, 86% had type 2 diabetes. Half of the patients (50.0%) were on insulin-based therapy, followed by 30.1% on a secretagoguebased regimen, 9.7% on non-secretagogue therapy, and 10.2% on a combination of insulin and secretagogue. Overall mean costs per patient were medication, 45.45 €; laboratory analysis, 218.14 €; examinations, 64.91 €; physician and nurse time, 268.55 € and 673.39 €, respectively. Bed occupancy was the main cost driver (772.09 €) and indirect cost averaged 140.44 €. Overall, the cost per hypoglycemia episode leading to hospitalization averaged 2042.52 € (range 194.76–16,762.87 €). Patients treated with insulin-based regimens (2267.76 €) and type 2 diabetes (2051.29 €) had the highest mean costs. The mean cost increased with repeated hypoglycemic events (2191.67 €), correlated complications (2109.26 €), and death (5253.38 €). Conclusion: HIPOS-WARD’s findings confirm and support both the substantial clinical and economic impact of hospitalization due to hypoglycemia in Portugal.
id RCAP_c8ea572b325f86c1af7021ced9d3b33f
oai_identifier_str oai:estudogeral.uc.pt:10316/105884
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting ApproachCost studyDiabetes mellitusHospitalizationHypoglycemiaIntroduction: Hypoglycemia leading to hospitalization is associated with adverse economic outcomes, although the real burden is unknown. The HIPOS-WARD (Hypoglycemia In Portugal Observational Study-Ward) aimed to characterize ward admissions due to hypoglycemia episodes in treated patients with diabetes and assess their economic impact to the National Health System. Methods: Observational, cross-sectional study, conducted in 16 Portuguese centers for 22 months. The applied microcosting approach was based on healthcare resource data, collected from patients’ charts upon ward admission until discharge, and unitary costs from official/ public data sources. Absenteeism was also estimated for active workers on the basis of the human capital approach. Results: Of the 176 patients with diabetes mellitus enrolled, 86% had type 2 diabetes. Half of the patients (50.0%) were on insulin-based therapy, followed by 30.1% on a secretagoguebased regimen, 9.7% on non-secretagogue therapy, and 10.2% on a combination of insulin and secretagogue. Overall mean costs per patient were medication, 45.45 €; laboratory analysis, 218.14 €; examinations, 64.91 €; physician and nurse time, 268.55 € and 673.39 €, respectively. Bed occupancy was the main cost driver (772.09 €) and indirect cost averaged 140.44 €. Overall, the cost per hypoglycemia episode leading to hospitalization averaged 2042.52 € (range 194.76–16,762.87 €). Patients treated with insulin-based regimens (2267.76 €) and type 2 diabetes (2051.29 €) had the highest mean costs. The mean cost increased with repeated hypoglycemic events (2191.67 €), correlated complications (2109.26 €), and death (5253.38 €). Conclusion: HIPOS-WARD’s findings confirm and support both the substantial clinical and economic impact of hospitalization due to hypoglycemia in Portugal.Springer Nature2020-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/105884http://hdl.handle.net/10316/105884https://doi.org/10.1007/s13300-020-00868-0eng1869-6953Ferreira, João Paulo MoraisAraújo, FranciscoDores, JorgeSantos, LélitaPape, EstevãoReis, MónicaChipepo, ÁrciaNascimento, EditeBaptista, AnaPires, VanessaMarques, CarlosLages, Adriana S.Conceição, JoãoLaires, Pedro A.Pelicano-Romano, JoãoAlão, Sílviainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-14T21:31:19Zoai:estudogeral.uc.pt:10316/105884Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:22:22.721492Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
title Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
spellingShingle Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
Ferreira, João Paulo Morais
Cost study
Diabetes mellitus
Hospitalization
Hypoglycemia
title_short Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
title_full Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
title_fullStr Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
title_full_unstemmed Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
title_sort Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
author Ferreira, João Paulo Morais
author_facet Ferreira, João Paulo Morais
Araújo, Francisco
Dores, Jorge
Santos, Lélita
Pape, Estevão
Reis, Mónica
Chipepo, Árcia
Nascimento, Edite
Baptista, Ana
Pires, Vanessa
Marques, Carlos
Lages, Adriana S.
Conceição, João
Laires, Pedro A.
Pelicano-Romano, João
Alão, Sílvia
author_role author
author2 Araújo, Francisco
Dores, Jorge
Santos, Lélita
Pape, Estevão
Reis, Mónica
Chipepo, Árcia
Nascimento, Edite
Baptista, Ana
Pires, Vanessa
Marques, Carlos
Lages, Adriana S.
Conceição, João
Laires, Pedro A.
Pelicano-Romano, João
Alão, Sílvia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferreira, João Paulo Morais
Araújo, Francisco
Dores, Jorge
Santos, Lélita
Pape, Estevão
Reis, Mónica
Chipepo, Árcia
Nascimento, Edite
Baptista, Ana
Pires, Vanessa
Marques, Carlos
Lages, Adriana S.
Conceição, João
Laires, Pedro A.
Pelicano-Romano, João
Alão, Sílvia
dc.subject.por.fl_str_mv Cost study
Diabetes mellitus
Hospitalization
Hypoglycemia
topic Cost study
Diabetes mellitus
Hospitalization
Hypoglycemia
description Introduction: Hypoglycemia leading to hospitalization is associated with adverse economic outcomes, although the real burden is unknown. The HIPOS-WARD (Hypoglycemia In Portugal Observational Study-Ward) aimed to characterize ward admissions due to hypoglycemia episodes in treated patients with diabetes and assess their economic impact to the National Health System. Methods: Observational, cross-sectional study, conducted in 16 Portuguese centers for 22 months. The applied microcosting approach was based on healthcare resource data, collected from patients’ charts upon ward admission until discharge, and unitary costs from official/ public data sources. Absenteeism was also estimated for active workers on the basis of the human capital approach. Results: Of the 176 patients with diabetes mellitus enrolled, 86% had type 2 diabetes. Half of the patients (50.0%) were on insulin-based therapy, followed by 30.1% on a secretagoguebased regimen, 9.7% on non-secretagogue therapy, and 10.2% on a combination of insulin and secretagogue. Overall mean costs per patient were medication, 45.45 €; laboratory analysis, 218.14 €; examinations, 64.91 €; physician and nurse time, 268.55 € and 673.39 €, respectively. Bed occupancy was the main cost driver (772.09 €) and indirect cost averaged 140.44 €. Overall, the cost per hypoglycemia episode leading to hospitalization averaged 2042.52 € (range 194.76–16,762.87 €). Patients treated with insulin-based regimens (2267.76 €) and type 2 diabetes (2051.29 €) had the highest mean costs. The mean cost increased with repeated hypoglycemic events (2191.67 €), correlated complications (2109.26 €), and death (5253.38 €). Conclusion: HIPOS-WARD’s findings confirm and support both the substantial clinical and economic impact of hospitalization due to hypoglycemia in Portugal.
publishDate 2020
dc.date.none.fl_str_mv 2020-10
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/105884
http://hdl.handle.net/10316/105884
https://doi.org/10.1007/s13300-020-00868-0
url http://hdl.handle.net/10316/105884
https://doi.org/10.1007/s13300-020-00868-0
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1869-6953
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134112939769856